Page last updated: 2024-09-05

sb 203580 and mefloquine

sb 203580 has been researched along with mefloquine in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(mefloquine)
Trials
(mefloquine)
Recent Studies (post-2010) (mefloquine)
3,48941,1372,212342560

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, TJ; Brumlik, MJ; Curiel, TJ; Kious, MJ; Nkhoma, S; Patterson, TF; Siekierka, JJ; Thompson, GR1

Other Studies

1 other study(ies) available for sb 203580 and mefloquine

ArticleYear
Human p38 mitogen-activated protein kinase inhibitor drugs inhibit Plasmodium falciparum replication.
    Experimental parasitology, 2011, Volume: 128, Issue:2

    Topics: Antimalarials; Chloroquine; Dose-Response Relationship, Drug; Erythrocytes; Humans; Imidazoles; Indoles; Inhibitory Concentration 50; Mefloquine; p38 Mitogen-Activated Protein Kinases; Plasmodium falciparum; Protein Kinase Inhibitors; Pyridines

2011